Karamehmet Yildiz

Karamehmet Yildiz

Auto-generated profile, based on publicly available information

Karamehmet Yildiz

Erciyes University

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Revista Brasileira de Anestesiologia
Verified
Journal Article
Open access
RARecep Aksu
Recep Aksu
CBCihangir Biçer
Cihangir Biçer
AÜAyşe Ülgey
Ayşe Ülgey
ABAdnan Bayram
Adnan Bayram
IGIşın Güneş
Işın Güneş
KYKaramehmet Yıldız
Karamehmet Yıldız
In this study, the aim was to compare postoperative analgesia effects of the administration of ultrasound-guided interscalene brachial plexus block and intra-articular bupivacaine carried out with bupivacaine. In the first group of patients 20mL 0.25% bupivacaine and ultrasound-guided interscalene brachial plexus block (ISPB) were applied, while 20mL 0.25% bupivacaine was given via intra-articular (IA) administration to the second group patients after surgery. Patients in the third group were considered the control group and no block was performed. Patient-controlled analgesia (PCA) with morphine was used in all three groups for postoperative analgesia. In the ISPB group, morphine consumption in the periods between 0-4, 6-12 and 12-24 postoperative hours and total consumption within 24h was lower than in the other two groups. Morphine consumption in the IA group was lower than in the control group in the period from 0 to 6h and the same was true for total morphine consumption in 24h. Postoperative VASr scores in the ISPB group were lower than both of the other groups in the first 2h and lower than the control group in the 4(th) and 6(th) hours (p<0.05). In the IA group, VASr and VASm scores in the 2(nd), 4(th) and 6(th) hours were lower than in the control group (p<0.05). Interscalene brachial plexus block was found to be more effective than intra-articular local anesthetic injection for postoperative analgesia.

1 January 2006 in Advances in Therapy
Verified
Journal Article
Closed access
PDF file
HGHulya Gultekin
Hulya Gultekin
KYKaramehmet Yildiz
Karamehmet Yildiz
ZSZafer Sezer
Zafer Sezer
KDKudret Dogru
Kudret Dogru

1 April 2011 in Current Therapeutic Research
Verified
Journal Article
Closed access
KYKaramehmet Yildiz
Karamehmet Yildiz
CBCihangir Bicer
Cihangir Bicer
RARecep Aksu
Recep Aksu
KDKudret Dogru
Kudret Dogru
HMHalit Madenoglu
Halit Madenoglu
ABAdem Boyaci
Adem Boyaci

30 August 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
HGHacı Semih GÜRCAN
Hacı Semih GÜRCAN
AÜAyşe Ülgey
Ayşe Ülgey
ÖGÖzlem Öz Gergi̇n
Özlem Öz Gergi̇n
SPSibel Seçki̇n Pehli̇vAn
Sibel Seçki̇n Pehli̇vAn
KYKaramehmet Yildiz
Karamehmet Yildiz
In this study, we aimed to compare the effects of propofol-ketamine and propofol-fentanyl sedations on post-procedure nausea-vomiting in children undergoing magnetic resonance imaging (MRI). This study included 100 pediatric patients (2-10 years old) who had propofol-ketamine and propofol-fentanyl for sedation to undergo MRI. The patients were divided into two groups, and sedation was performed through propofol-ketamine (Group K; n=50) or propofol-fentanyl (Group F; n=50). For sedation induction, intravenous (IV) bolus of 1.2 mg/kg propofol and 1 mg/kg ketamine were administered in Group K, IV bolus of 1.2 mg/kg propofol and 1 µg/kg fentanyl in Group F. All patients received 0.5 mg/kg IV bolus propofol in additional doses when the Ramsey Sedation Score (RSS) was below 4 for maintenance. Perioperative heart rate, systolic arterial pressure, peripheral oxygen saturation, respiratory rate, and nausea-vomiting scores were recorded for each patient. There was no difference between the groups in terms of nausea incidences at the 1st hour. However, the rate of vomiting was significantly higher in Group K. In our study, we showed that the vomiting rate was higher in the 1st hour in Group K compared to Group F.

26 June 2022 in Toxicology Mechanisms and Methods
Verified
Journal Article
Closed access
ÖGÖzlem Öz Gergin
Özlem Öz Gergin
IGİsMail Şamil Gergin
İsMail Şamil Gergin
SPSibel Seckin Pehlivan
Sibel Seckin Pehlivan
OMOzge cengiz mat
Ozge cengiz mat
ITIşıl Tuğçe Turan
Işıl Tuğçe Turan
AYArzu Yay
Arzu Yay
Colistin is an effective antibiotic against multidrug-resistant gram-negative bacterial infections; however, neurotoxic effects are fundamental dose-limiting factors for this treatment. Stem cell therapy is a promising method for treating neuronal diseases. Multipotent mesenchymal stromal cells (MSC) represent a promising source for regenerative medicine. Identification of neuroprotective agents that can be co-administered with colistin has the potential to allow the clinical application of this essential drug. This study was conducted to assess the potential protective effects of MSC, against colistin-induced neurotoxicity, and the possible mechanisms underlying any effect. Forty adult female albino rats were randomly classified into four equal groups; the control group, the MSC-treated group (A single dose of 1 × 106/mL MSCs through the tail vein), the colistin-treated group (36 mg/kg/d colistin was given for 7 d) and the colistin and MSC treated group (36 mg/kg/d colistin was administered for 7 d, and 1 × 106/mL MSCs). Colistin administration significantly increased GFAP, NGF, Beclin-1, IL-6, and TNF-α immunreactivity intensity. MSC administration in colistin-treated rats partially restored each of these markers. Histopathological changes in brain tissues were also alleviated by MSC co-treatment. Our study reveals a critical role of inflammation, autophagy, and apoptosis in colistin-induced neurotoxicity and showed that they were markedly ameliorated by MSC co-administration. Therefore, MSC could represent a promising agent for prevention of colistin-induced neurotoxicity.

4 August 2023 in Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
ÖGÖzlem Öz Gergi̇n
Özlem Öz Gergi̇n
SPSibel Seçkin Pehli̇vAn
Sibel Seçkin Pehli̇vAn
OŞOğuz Kaan Şi̇mŞek
Oğuz Kaan Şi̇mŞek
IEİbRahim Erkan
İbRahim Erkan
KYKaramehmet Yildiz
Karamehmet Yildiz
MKMehmet Köse
Mehmet Köse
The use of the laryngeal mask (LMA) during flexible fiberoptic bronchoscopy (FOB) is more advantageous compared to other airway devices. In this study, the use of LMA for airway maintenance in FOB in pediatric patients was planned to be reviewed in the light of the literature by evaluating the postoperative complications encountered with the demographics of the patients, the duration of anesthesia, and bronchoscopic diagnoses. Between January 2017 and January 2022, the files of pediatric patients who underwent FOB were reviewed retrospectively. The patients' demographics, the airway device used for airway maintenance in FOB (LMA, endotracheal tube, tracheal tube), bronchoscopy indications, bronchoscopic diagnoses, duration of anesthesia, post-procedure hypoxia, laryngospasm, and the number of patients requiring bronchospasm were all recorded. The study included 162 pediatric patients ranging in age from 0 to 17. The median age was 6.9 years old (interquartile range 0-17 years old), and the median weight was 24.5 kg (interquartile range 2.5-89). The patient group having thoracic CT abnormalities and requiring an operation to support the diagnosis was the most prevalent FOB indication (n=37, 22.8%). In all, 28 patients (17.3%) experienced temporary hypoxia, whereas 62 patients (38.3%) experienced bronchospasm. In pediatric patients, FOB via LMA is a safe method. Appropriate equipment, experienced personnel, good patient selection, and adequate follow-up of the patient after bronchoscopy are among the most important factors in the prevention and reduction of complications.